Efficacy & Safety of Famitinib Versus Sunitinib in the Treatment of

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05385549` - 5 Years of Adjuvant Imatinib in Patients With Gastrointestinal Stromal Tumor With a High Risk	Phase 2
Recruiting	`NCT05905887` - Rivoceranib Plus Paclitaxel in Patients With Gastrointestinal Stromal Tumor	Phase 2
Completed	`NCT01933958` - Regorafenib Post-marketing Surveillance in Japan
Recruiting	`NCT04584008` - Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics	N/A
Completed	`NCT01440959` - Dovitinib for Imatinib/Sumitinib-failed Gastrointestinal Stromal Tumors (GIST): TKI258	Phase 2
Completed	`NCT00718562` - Efficacy and Safety of AMN107 in Patients With GastroIntestinal Stromal Tumors (GIST) Who Have Failed Both Imatinib and Sunitinib	Phase 2
Completed	`NCT00385203` - The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST).	Phase 2
Completed	`NCT00137449` - Study Of SU011248 Administered On A Continuous Daily Dosing Schedule In Patients With Gastrointestinal Stromal Tumor	Phase 2
Completed	`NCT00237172` - Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors (Extension Study)	Phase 2
Active, not recruiting	`NCT03556384` - Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST)	Phase 2
Recruiting	`NCT04106024` - Efficacy and Safety of Anlotinib in Patients With Advanced Gastrointestinal Stromal Tumor After Failure of Imatinib: a Prospective, Single Arm and Multicenter Trial	Phase 2
Completed	`NCT02171286` - The Oncopanel Pilot (TOP) Study	N/A
Completed	`NCT01114087` - Impact of the Inhibitors of Tyrosine Kinase on the Male Fertility	N/A
Recruiting	`NCT05366816` - ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST	Phase 2
Recruiting	`NCT03602092` - Observational Registry Data on GIST Patients
Recruiting	`NCT05197933` - Safety of Laparoscopic Resection for Gastrointestinal Stromal Tumor on Unfavorable Anatomic Site of Stomach	N/A
Completed	`NCT02931929` - MITIGATE-NeoBOM: A Study to Evaluate 68Ga- NeoBOMB1 in Patients With Advanced TKI-treated GIST Using PET/CT	Phase 1/Phase 2
Withdrawn	`NCT05080621` - Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST)	Phase 1/Phase 2
Completed	`NCT02638766` - Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST	Phase 2
Completed	`NCT02607332` - Paclitaxel in Patients With Metastatic or Advanced Gastrointestinal Stromal Tumors (GIST) After Failure to Imatinib and Sunitinib	Phase 2

NCT number	NCT04409223
Study type	Interventional
Source	Jiangsu HengRui Medicine Co., Ltd.
Contact
Status	Terminated
Phase	Phase 3
Start date	September 12, 2020
Completion date	March 25, 2022

Efficacy and Safety of Famitinib Versus Sunitinib in the Treatment of Advanced Gastrointestinal Stromal Tumour Patients After Failure of Imatinib

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms